Effect of breed on response to foot rot treatment in mature sheep and lambs
Abstract Our objective was to determine whether breed differences existed in response to exposure and treatment of virulent foot rot. Dorset (DS), 1/2 Dorper (DX), 3/4 or greater Dorper (DO), Gulf Coast Native (GC), Katahdin (KA), and St. Croix (SC) mature sheep and lambs were exposed to virulent foot rot in spring 2003. Treatment for foot rot was initiated in 132 lambs and 262 mature sheep in late July. There were eight pasture groups treated, two of which were minimally exposed to foot rot. Treatment included hoof paring, foot bathing with 10% zinc sulfate with surfactant, allowing the zinc sulfate to dry on the foot and moving to a small paddock that had not been exposed to small ruminants for more than 14 d. Foot bathing was repeated every 7 d for a maximum of five treatments. Animals that had not responded (odor or any indication of persistent infection) by then were culled from the flock. As an indication of severity of foot rot for each animal, the number of areas on the foot (interdigital and two digits for each foot), a foot score (0 = no infection found; 1 = infection of digits only; 2 = infection of interdigital area and could include digits), and presence of characteristic odor was recorded. Least squares means for number of areas infected were greater for mature than growing sheep (2.07 ± 0.16 versus 0.88 ± 0.31; P P P P P P P P
The effect of time between doses on serological response to a recombinant multivalent pilus vaccine against footrot in sheep.
The response of sheep to a recombinant multivalent footrot vaccine containing pilus antigens was examined after the administration of two doses of vaccine at intervals ranging from 2 to 52 weeks. Agglutinating antibody titres were measured 3 weeks after the second vaccination and showed that lengthening of the interdose interval results in higher agglutinin titres. The capability of sheep to mount an increasingly strong immune response as the interval between doses is increased provides an opportunity to maximise the usefulness of vaccination by administering the first dose well before an expected footrot transmission period. This advantage of increasing the interdose interval has not been reported for traditional, whole-cell footrot vaccines, and use of the new pilus vaccine in this manner may improve prospects for disease control. Furthermore, sheep given a third dose either 6 or 12 months after their initial two-dose vaccination program achieved significantly higher titres than those elicited after the second dose, suggesting the likelihood of further improvement in disease control in successive seasons.
The effects of antigenic competition on the efficacy of multivalent footrot vaccines.
A multivalent footrot vaccine has been developed, containing pilus antigens produced in recombinant Pseudomonas aeruginosa and representing all nine serogroups of Dichelobacter (Bacteroides) nodosus commonly recognised in the field. The responses of sheep to the multivalent vaccine have been compared with those to monovalent vaccines representing only a single serogroup. Antigenic competition between serogroups occurred in sheep immunised with the multivalent formation, but high levels of protection were still achieved. The study showed that in multivalent footrot vaccines, antigenic competition is predominantly due to the presence of a family of immunologically-related pilus antigens rather than to interference by extraneous proteins.